EHA | European Hematology Association
EHA 2024
Promising Avenues for the Development of Personalized Treatment for FVII Deficiency
/ Maria Eugenia Chollet
Events | 2023
An Excellent Target with a Wide Therapeutic Window in del(5q) Myeloid Malignancies
/ Sergio Martinez Høyer
Management of ALL in Adults: 2024 ELN Recommendations
/ Henrik Hjorth-Hansen
Development of Prediction Models for Survival among Hodgkin Lymphoma Patients
/ Rasmus Rask Kragh Jørgensen
Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes
/ Ângela Sofia Gerós Mesquita
EHA 2023
Mer
The Missing Link of Light Chain Smoldering Multiple Myeloma
/ Sigrun Thorsteinsdottir
Functional Characterization for Germline Variants in Patients with MDS and AML
/ Nikolaj Juul Nitschke